Mission Street at Future Cities Forum's 'Oxfordshire and the Ox Cam Growth Corridor' this January

Image: Inventa, purpose-built office and lab space on Oxford West End (courtesy OWA for Mission Street)

Future Cities Forum is delighted that Artem Korolev, Founder and CEO of Mission Street, will be contributing to our Oxford 'Science Cities - Oxfordshire and the Growth Corridor' discussion event this month in the Cheng Kar Shun Digital Hub at Jesus College..

Artem founded Mission Street in 2017. Building on extensive track record across investment, development and finance, he has overall strategic responsibility for the growth of the company, project delivery and management.

Prior to Mission Street, Artem was Head of UK Acquisitions and a member of the founding team of GreenOak Real Estate (now BGO), a major international real estate investment and asset management firm (at the time with c. £10bn under management). He also previously worked for Morgan Stanley in their UK Real Estate team.

Artem’s track record spans development, asset management, real estate private equity and finance. This has included property acquisitions and corporate M&A, leading end-to-end delivery of complex development and asset management projects across the UK, and structuring debt and equity financing (both as the operating partner and capital partner).

Artem graduated with an MA (First Class Honours) in Land Economy at the University of Cambridge and sits on the Investment and Development Committee for the Institute of Cancer Research.

Oxford Cancer Analytics, a fast-scaling diagnostics company, has recently signed for Mission Street and BGO’s Inventa, taking the building in Oxford’s West End to close to fully occupied.

OXcan has committed to a new lease of 2,400 square feet and is moving from the BioEscalator to Inventa. Founded in 2019, OXcan recently completed its Series A funding round, led by We Venture Capital and Cross-Border Impact Ventures.

The letting at the 65,000-square-foot Inventa is the fourth. Previous deals comprise Nucleome which took 20,000 square feet, Xyme which took 5,600 square feet and Oxford Symantic Technologies, which took 4,300 square feet. The building includes 9,000 square feet of collaboration space.

Mission Street was established in 2017 as an investor, developer and operator specialising in the sciences and innovation sector.

It is at various stages of developing an 1.5 million square feet pipeline in Oxford, Cambridge and Bristol.

BGO is a leading, global real estate investment management advisor and provider of real estate services. It has around $89 billion of assets under management as of 30 September. BGO is a part of SLC Management, the institutional alternatives and traditional asset management business of Sun Life.

Mission Street began construction of a second development phase at Oxford West End, Fabrica, in September, with the property set to provide an additional 183,000 square feet of labs and offices across five storeys.

It says the project highlights the duo’s conviction in Oxford’s West End, with the urban innovation hub having a long-term pipeline of 2 million square feet of commercial science and innovation space.

Image: Artem Korolev -courtesy of Mission Street